ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liquid Embolic Agent Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-4K10671
Home | Market Reports | Health| Medical Devices & Equipment
Global Liquid Embolic Agent Market Research Report 2022
BUY CHAPTERS

Global Liquid Embolic Agent Market Research Report 2025

Code: QYRE-Auto-4K10671
Report
February 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Meril Life
Saikesaisi Holding
Balt Group
Johnson & Johnson
BlackSwan Vascular

Liquid Embolic Agent Market

The global market for Liquid Embolic Agent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Liquid Embolic Agent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Liquid Embolic Agent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Liquid Embolic Agent include Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Saikesaisi Holding, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liquid Embolic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Embolic Agent.
The Liquid Embolic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liquid Embolic Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Embolic Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Liquid Embolic Agent Market Report

Report Metric Details
Report Name Liquid Embolic Agent Market
Segment by Type
  • EVOH Type
  • nBCA Type
  • Other
Segment by Application
  • Cerebral Arteriovenous Malformations (AVMs)
  • Dural Arteriovenous Fistulas (DAVFs)
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Saikesaisi Holding
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Liquid Embolic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Liquid Embolic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Liquid Embolic Agent Market report?

Ans: The main players in the Liquid Embolic Agent Market are Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Saikesaisi Holding

What are the Application segmentation covered in the Liquid Embolic Agent Market report?

Ans: The Applications covered in the Liquid Embolic Agent Market report are Cerebral Arteriovenous Malformations (AVMs), Dural Arteriovenous Fistulas (DAVFs), Other

What are the Type segmentation covered in the Liquid Embolic Agent Market report?

Ans: The Types covered in the Liquid Embolic Agent Market report are EVOH Type, nBCA Type, Other

1 Liquid Embolic Agent Market Overview
1.1 Product Definition
1.2 Liquid Embolic Agent by Type
1.2.1 Global Liquid Embolic Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 EVOH Type
1.2.3 nBCA Type
1.2.4 Other
1.3 Liquid Embolic Agent by Application
1.3.1 Global Liquid Embolic Agent Market Value by Application (2024 VS 2031)
1.3.2 Cerebral Arteriovenous Malformations (AVMs)
1.3.3 Dural Arteriovenous Fistulas (DAVFs)
1.3.4 Other
1.4 Global Liquid Embolic Agent Market Size Estimates and Forecasts
1.4.1 Global Liquid Embolic Agent Revenue 2020-2031
1.4.2 Global Liquid Embolic Agent Sales 2020-2031
1.4.3 Global Liquid Embolic Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Liquid Embolic Agent Market Competition by Manufacturers
2.1 Global Liquid Embolic Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Liquid Embolic Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Liquid Embolic Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Liquid Embolic Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liquid Embolic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liquid Embolic Agent, Product Type & Application
2.7 Global Key Manufacturers of Liquid Embolic Agent, Date of Enter into This Industry
2.8 Global Liquid Embolic Agent Market Competitive Situation and Trends
2.8.1 Global Liquid Embolic Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Liquid Embolic Agent Players Market Share by Revenue
2.8.3 Global Liquid Embolic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Liquid Embolic Agent Market Scenario by Region
3.1 Global Liquid Embolic Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Liquid Embolic Agent Sales by Region: 2020-2031
3.2.1 Global Liquid Embolic Agent Sales by Region: 2020-2025
3.2.2 Global Liquid Embolic Agent Sales by Region: 2026-2031
3.3 Global Liquid Embolic Agent Revenue by Region: 2020-2031
3.3.1 Global Liquid Embolic Agent Revenue by Region: 2020-2025
3.3.2 Global Liquid Embolic Agent Revenue by Region: 2026-2031
3.4 North America Liquid Embolic Agent Market Facts & Figures by Country
3.4.1 North America Liquid Embolic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Liquid Embolic Agent Sales by Country (2020-2031)
3.4.3 North America Liquid Embolic Agent Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Liquid Embolic Agent Market Facts & Figures by Country
3.5.1 Europe Liquid Embolic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Liquid Embolic Agent Sales by Country (2020-2031)
3.5.3 Europe Liquid Embolic Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liquid Embolic Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Liquid Embolic Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Liquid Embolic Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Liquid Embolic Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Liquid Embolic Agent Market Facts & Figures by Country
3.7.1 Latin America Liquid Embolic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Liquid Embolic Agent Sales by Country (2020-2031)
3.7.3 Latin America Liquid Embolic Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liquid Embolic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Liquid Embolic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Liquid Embolic Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Liquid Embolic Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Liquid Embolic Agent Sales by Type (2020-2031)
4.1.1 Global Liquid Embolic Agent Sales by Type (2020-2025)
4.1.2 Global Liquid Embolic Agent Sales by Type (2026-2031)
4.1.3 Global Liquid Embolic Agent Sales Market Share by Type (2020-2031)
4.2 Global Liquid Embolic Agent Revenue by Type (2020-2031)
4.2.1 Global Liquid Embolic Agent Revenue by Type (2020-2025)
4.2.2 Global Liquid Embolic Agent Revenue by Type (2026-2031)
4.2.3 Global Liquid Embolic Agent Revenue Market Share by Type (2020-2031)
4.3 Global Liquid Embolic Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Liquid Embolic Agent Sales by Application (2020-2031)
5.1.1 Global Liquid Embolic Agent Sales by Application (2020-2025)
5.1.2 Global Liquid Embolic Agent Sales by Application (2026-2031)
5.1.3 Global Liquid Embolic Agent Sales Market Share by Application (2020-2031)
5.2 Global Liquid Embolic Agent Revenue by Application (2020-2031)
5.2.1 Global Liquid Embolic Agent Revenue by Application (2020-2025)
5.2.2 Global Liquid Embolic Agent Revenue by Application (2026-2031)
5.2.3 Global Liquid Embolic Agent Revenue Market Share by Application (2020-2031)
5.3 Global Liquid Embolic Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Liquid Embolic Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Liquid Embolic Agent Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Balt Group
6.2.1 Balt Group Company Information
6.2.2 Balt Group Description and Business Overview
6.2.3 Balt Group Liquid Embolic Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Balt Group Liquid Embolic Agent Product Portfolio
6.2.5 Balt Group Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Liquid Embolic Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Liquid Embolic Agent Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Meril Life
6.4.1 Meril Life Company Information
6.4.2 Meril Life Description and Business Overview
6.4.3 Meril Life Liquid Embolic Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Meril Life Liquid Embolic Agent Product Portfolio
6.4.5 Meril Life Recent Developments/Updates
6.5 BlackSwan Vascular
6.5.1 BlackSwan Vascular Company Information
6.5.2 BlackSwan Vascular Description and Business Overview
6.5.3 BlackSwan Vascular Liquid Embolic Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BlackSwan Vascular Liquid Embolic Agent Product Portfolio
6.5.5 BlackSwan Vascular Recent Developments/Updates
6.6 Saikesaisi Holding
6.6.1 Saikesaisi Holding Company Information
6.6.2 Saikesaisi Holding Description and Business Overview
6.6.3 Saikesaisi Holding Liquid Embolic Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Saikesaisi Holding Liquid Embolic Agent Product Portfolio
6.6.5 Saikesaisi Holding Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liquid Embolic Agent Industry Chain Analysis
7.2 Liquid Embolic Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liquid Embolic Agent Production Mode & Process Analysis
7.4 Liquid Embolic Agent Sales and Marketing
7.4.1 Liquid Embolic Agent Sales Channels
7.4.2 Liquid Embolic Agent Distributors
7.5 Liquid Embolic Agent Customer Analysis
8 Liquid Embolic Agent Market Dynamics
8.1 Liquid Embolic Agent Industry Trends
8.2 Liquid Embolic Agent Market Drivers
8.3 Liquid Embolic Agent Market Challenges
8.4 Liquid Embolic Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Medtronic Inc
Meril Life
Saikesaisi Holding
Balt Group
Johnson & Johnson
BlackSwan Vascular
List of Tables
 Table 1. Global Liquid Embolic Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Liquid Embolic Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Liquid Embolic Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Liquid Embolic Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Liquid Embolic Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Liquid Embolic Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Liquid Embolic Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Liquid Embolic Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Liquid Embolic Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Liquid Embolic Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Liquid Embolic Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Liquid Embolic Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Liquid Embolic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Embolic Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Liquid Embolic Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Liquid Embolic Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Liquid Embolic Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Liquid Embolic Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Liquid Embolic Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Liquid Embolic Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Liquid Embolic Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Liquid Embolic Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Liquid Embolic Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Liquid Embolic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Liquid Embolic Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Liquid Embolic Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Liquid Embolic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Liquid Embolic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Liquid Embolic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Liquid Embolic Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Liquid Embolic Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Liquid Embolic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Liquid Embolic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Liquid Embolic Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Liquid Embolic Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Liquid Embolic Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Liquid Embolic Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Liquid Embolic Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Liquid Embolic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Liquid Embolic Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Liquid Embolic Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Liquid Embolic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Liquid Embolic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Liquid Embolic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Liquid Embolic Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Liquid Embolic Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Liquid Embolic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Liquid Embolic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Liquid Embolic Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Liquid Embolic Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Liquid Embolic Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Liquid Embolic Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Liquid Embolic Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Liquid Embolic Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Liquid Embolic Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Liquid Embolic Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Liquid Embolic Agent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Liquid Embolic Agent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Liquid Embolic Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Liquid Embolic Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Liquid Embolic Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Liquid Embolic Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Liquid Embolic Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Liquid Embolic Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Liquid Embolic Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Liquid Embolic Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Liquid Embolic Agent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Liquid Embolic Agent Price (US$/Unit) by Application (2026-2031)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Medtronic Liquid Embolic Agent Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Balt Group Company Information
 Table 76. Balt Group Description and Business Overview
 Table 77. Balt Group Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Balt Group Liquid Embolic Agent Product
 Table 79. Balt Group Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Liquid Embolic Agent Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Meril Life Company Information
 Table 86. Meril Life Description and Business Overview
 Table 87. Meril Life Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Meril Life Liquid Embolic Agent Product
 Table 89. Meril Life Recent Developments/Updates
 Table 90. BlackSwan Vascular Company Information
 Table 91. BlackSwan Vascular Description and Business Overview
 Table 92. BlackSwan Vascular Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. BlackSwan Vascular Liquid Embolic Agent Product
 Table 94. BlackSwan Vascular Recent Developments/Updates
 Table 95. Saikesaisi Holding Company Information
 Table 96. Saikesaisi Holding Description and Business Overview
 Table 97. Saikesaisi Holding Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Saikesaisi Holding Liquid Embolic Agent Product
 Table 99. Saikesaisi Holding Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Liquid Embolic Agent Distributors List
 Table 103. Liquid Embolic Agent Customers List
 Table 104. Liquid Embolic Agent Market Trends
 Table 105. Liquid Embolic Agent Market Drivers
 Table 106. Liquid Embolic Agent Market Challenges
 Table 107. Liquid Embolic Agent Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Liquid Embolic Agent
 Figure 2. Global Liquid Embolic Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Liquid Embolic Agent Market Share by Type: 2024 & 2031
 Figure 4. EVOH Type Product Picture
 Figure 5. nBCA Type Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Liquid Embolic Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Liquid Embolic Agent Market Share by Application: 2024 & 2031
 Figure 9. Cerebral Arteriovenous Malformations (AVMs)
 Figure 10. Dural Arteriovenous Fistulas (DAVFs)
 Figure 11. Other
 Figure 12. Global Liquid Embolic Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Liquid Embolic Agent Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Liquid Embolic Agent Sales (2020-2031) & (K Units)
 Figure 15. Global Liquid Embolic Agent Average Price (US$/Unit) & (2020-2031)
 Figure 16. Liquid Embolic Agent Report Years Considered
 Figure 17. Liquid Embolic Agent Sales Share by Manufacturers in 2024
 Figure 18. Global Liquid Embolic Agent Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Liquid Embolic Agent Players: Market Share by Revenue in Liquid Embolic Agent in 2024
 Figure 20. Liquid Embolic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Liquid Embolic Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Liquid Embolic Agent Sales Market Share by Country (2020-2031)
 Figure 23. North America Liquid Embolic Agent Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Liquid Embolic Agent Sales Market Share by Country (2020-2031)
 Figure 27. Europe Liquid Embolic Agent Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Liquid Embolic Agent Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Liquid Embolic Agent Revenue Market Share by Region (2020-2031)
 Figure 35. China Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Liquid Embolic Agent Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Liquid Embolic Agent Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Liquid Embolic Agent Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Liquid Embolic Agent Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Liquid Embolic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Liquid Embolic Agent by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Liquid Embolic Agent by Type (2020-2031)
 Figure 57. Global Liquid Embolic Agent Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Liquid Embolic Agent by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Liquid Embolic Agent by Application (2020-2031)
 Figure 60. Global Liquid Embolic Agent Price (US$/Unit) by Application (2020-2031)
 Figure 61. Liquid Embolic Agent Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Liquid Embolics Market Research Report 2024
Global Liquid Embolic System Market Research Report 2025
Global Peripheral Liquid Embolic Agents Market Research Report 2024
Blood Vessels Embolic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Embolic Protection Systems Market Research Report 2024
Vascular Embolization Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liquid Embolic Device Market Research Report 2025
Global Liquid Water holding Agent Market Research Report 2025
Global Embolic Agents Market Research Report 2024
Global Spiral Embolism Market Research Report 2024
Cardiovascular Embolic Protection Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Disposable Embolic Protection Device Market Research Report 2024
Global Embolization in Interventional Oncology Market Research Report 2024
Global Coronary Embolic Protection Device Market Research Report 2024
Global Tumor Embolization Market Research Report 2024
Global Hemostatic Agents Market Research Report 2025
Global Emulsion Release Agent Market Research Report 2024
Global Catheter Embolization Market Research Report 2024
Global Carotid Embolic Protection Device Market Research Report 2025
Global Liquid Fibrin Sealants Market Research Report 2024

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions